Company intelligence / Profile preview

ComBrio

San Jose, California, USA

Ownership: Private
Development stage: Other

Overview

Combrio was a medical device company focused on developing minimally invasive solutions for the treatment of chronic sinusitis. The company's primary technology was a balloon dilation system designed to open blocked sinus passages, providing a less invasive alternative to traditional sinus surgery. Founded within the InCube Labs incubator, Combrio aimed to improve patient recovery times and clinical outcomes in the field of otolaryngology. The company was acquired by Entellus Medical in 2011, which further integrated the technology into its ENT portfolio before being acquired by Stryker.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on ComBrio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ComBrio.

Explore the full profile